Kyowa Hakko Bio, a direct subsidiary of Kirin Holdings Co. Ltd., is a health science division bridging between food and pharma, to move from the present age of treatment to a future age of prevention. Pioneers in the development and application of patented fermentation technology since 1949, Kyowa Hakko Bio is a Japan-based global specialty fermentation and research company for high quality health-enhancing ingredients such as “Kyowa Quality” amino acids, nucleic acids, branded ingredients, postbiotics and human milk oligosaccharides which contribute to health and well-being of people around the world, through supplements and functional food, supported by robust clinical documentation.